methotrexate has been researched along with Arthritis, Spinal in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (23.53) | 29.6817 |
| 2010's | 17 (50.00) | 24.3611 |
| 2020's | 9 (26.47) | 2.80 |
| Authors | Studies |
|---|---|
| Ben Ammar, L; Ben Nessib, D; Ferjani Hanene, L; Hamdi, W; Kaffel, D; Maatallah, K; Triki, W | 1 |
| Aikawa, NE; Bonfa, E; C B Moraes, J; F N Yuki, E; G Pasoto, S; G S Saad, C; G Schainberg, C; Gonçalves, CR; K Aoyama, R; Medeiros-Ribeiro, AC; S R Araujo, C; S R Silva, M; Sampaio-Barros, PD; Shimabuco, AY; Silva, CA; V K Kupa, L | 1 |
| Amital, H; Poddubnyy, D; Rubbert-Roth, A | 1 |
| Andras, L; Armingeat, T; Cormier, G; de Vries, A; Dernis, E; Desvignes, C; Devauchelle-Pensec, V; Ducourau, E; Gervais, E; Goupille, P; Le Goff, B; Le Guilchard, F; Lespessailles, E; Martin, A; Mulleman, D; Paintaud, G; Perdriger, A; Piver, E; Rispens, T; Samain, M; Ternant, D; Watier, H | 1 |
| Abramson, SB; Nayak, RR; Scher, JU; Turnbaugh, PJ; Ubeda, C | 1 |
| Antonisamy, B; Danda, D; Ganapati, A; Gowri, M | 1 |
| Emeanuru, K; Glynn, M; Guerette, B; Harrold, LR; Liu, M; Mease, PJ; Ogdie, A; Richter, S | 1 |
| Carron, P; Colman, R; De Craemer, AS; Elewaut, D; Renson, T; Van den Bosch, F | 1 |
| Furuta, S; Furuya, H; Iida, K; Ikeda, K; Iwamoto, T; Iwata, A; Kasuya, T; Kato, M; Kawakami, E; Kumagai, T; Mimura, N; Nakajima, H; Nishimura, N; Suga, K; Sugiyama, T; Suto, A; Suzuki, K; Tanaka, S | 1 |
| Asikainen, J; Borodina, J; Eklund, KK; Ekman, P; Elfving, P; Hiltunen, J; Isomäki, P; Jokiranta, TS; Kaipiainen-Seppänen, O; Kauppi, MJ; Kautiainen, H; Kortelainen, S; Lamberg, T; Leirisalo-Repo, M; Paalanen, K; Parmanne, P; Peltomaa, R; Pirilä, L; Rantalaiho, V; Relas, H; Romu, M; Santisteban, A; Sokka, T; Tadesse, K; Taimen, K; Tuompo, R; Uutela, T; Valleala, H; Vidqvist, KL; Yli-Kerttula, T | 1 |
| Balsa, A; Calvo-Alén, J; Carmona, L; Martín-López, M; Rosas, J; Sanmartí, R; Tornero, J | 1 |
| Armuzzi, A; Felice, C; Gasbarrini, A; Guidi, L; Onori, E; Papparella, LG; Pizzolante, F; Pugliese, D; Rapaccini, GL | 1 |
| Claudepierre, P | 1 |
| John, KJ; Sadiq, M; Thomas, M; Turaka, VP | 1 |
| Briot, K; Dougados, M; Durnez, A; Fechtenbaum, J; Landewé, RB; Paternotte, S; Roux, C | 1 |
| Adami, S; Addimanda, O; Bortoluzzi, A; Caimmi, C; De Vita, S; Ferri, C; Govoni, M; Lo Monaco, A; Manfredi, A; Orsolini, G; Possemato, N; Quartuccio, L; Rossini, M; Salvarani, C; Zabotti, A | 1 |
| Askling, J; Forsblad-d'Elia, H; Jacobsson, LT; Kristensen, LE; Lie, E; Zverkova-Sandström, T | 1 |
| Lian, F; Liang, L; Wang, Y; Wei, C; Xu, H; Yang, X; Zhou, J | 1 |
| Arfi, S; Blettery, M; Brunier, L; De Bandt, M; Deligny, C; Jean-Baptiste, G; Moinet, F; Polomat, K | 1 |
| Gran, JT; Nossent, JC | 1 |
| Baraliakos, X; Braun, J | 1 |
| Argin, M; Gumusdis, G; Kabasakal, Y; Kitapcioglu, G; Taylan, A; Yargucu, F | 1 |
| de Vlam, K; Lories, RJ; Van Tilt, I; Westhovens, R | 1 |
| Ahmed, MH; El Baz, WF; El Labaan, A; Hamaad, Y; Soliman, E; Tayel, MY | 1 |
| Ceccarelli, F; DI Franco, M; Iannuccelli, C; Paradiso, M; Scrivo, R; Spinelli, FR; Valesini, G | 1 |
| Colebatch, AN; Edwards, CJ; Marks, JL | 1 |
| Ito, H; Kiyokawa, T; Maeda, A; Nagafuchi, H; Nakano, H; Ogawa, H; Ooka, S; Ozaki, S; Shibata, T; Takakuwa, Y; Tonooka, K; Yamada, H; Yamasaki, Y | 1 |
| Krüger, K; Sieper, J | 1 |
| Mease, PJ | 1 |
| Chinoy, H; Foulkes, AC; Griffiths, CE; Warren, RB | 1 |
| El Maghraoui, A | 1 |
| Bresnihan, B | 1 |
| Braun, J; Sieper, J | 1 |
| Baglin, A; Hanslik, T; Lortholary, O; Massoumi, A; Prinseau, J; Soussan, P; Tnani, N | 1 |
11 review(s) available for methotrexate and Arthritis, Spinal
| Article | Year |
|---|---|
Should we combine biologics with methotrexate in axial spondyloarthritis?
Topics: Antirheumatic Agents; Biological Products; Humans; Methotrexate; Spondylarthritis | 2019 |
Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmunity; Biological Availability; Gastrointestinal Microbiome; Humans; Methotrexate; Mice; Precision Medicine; Spondylarthritis; Tumor Necrosis Factor Inhibitors | 2020 |
Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biological Factors; Biological Products; Drug Therapy, Combination; Humans; Methotrexate; Spondylarthritis | 2018 |
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Evidence-Based Medicine; Humans; Inflammatory Bowel Diseases; Methotrexate; Spondylarthritis; Steroids; Sulfasalazine; Tumor Necrosis Factor-alpha; Ustekinumab | 2018 |
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Glucocorticoids; Humans; Methotrexate; Prognosis; Remission Induction; Severity of Illness Index; Spondylarthritis; Time Factors; Treatment Failure | 2014 |
Treatment of ankylosing spondylitis and other spondyloarthritides.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Disease Progression; Humans; Immunologic Factors; Methotrexate; Osteogenesis; Spondylarthritis; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2009 |
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Aspirin; Drug Interactions; Drug Therapy, Combination; Humans; Methotrexate; Randomized Controlled Trials as Topic; Spondylarthritis; Spondylitis, Ankylosing | 2011 |
[Off-label therapy of rheumatoid arthritis and spondyloarthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Dose-Response Relationship, Drug; Drug Approval; Drug Costs; Drug Therapy, Combination; Germany; Humans; Insurance, Pharmaceutical Services; Isoxazoles; Leflunomide; Methotrexate; National Health Programs; Off-Label Use; Reimbursement Mechanisms; Spondylarthritis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
[Ankylosing spondylitis].
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Reactive; Behcet Syndrome; Diagnosis, Differential; Diphosphonates; Humans; Immunosuppressive Agents; Lung; Methotrexate; Pamidronate; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine; Thalidomide; Tomography, X-Ray Computed | 2004 |
Synovial biomarkers in the spondylarthropathies.
Topics: Biomarkers; Humans; Metalloproteases; Methotrexate; Spondylarthritis; Synovial Membrane; Tissue Inhibitor of Metalloproteinases; Tumor Necrosis Factor-alpha | 2006 |
[Management of cytomegalovirus infections in patients treated with immunosuppressive drugs for chronic inflammatory diseases].
Topics: Antiviral Agents; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Opportunistic Infections; Spondylarthritis; Valganciclovir | 2008 |
2 trial(s) available for methotrexate and Arthritis, Spinal
| Article | Year |
|---|---|
Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Axial Spondyloarthritis; COVID-19; COVID-19 Vaccines; Female; Humans; Male; Methotrexate; Prednisone; Prospective Studies; SARS-CoV-2; Spondylarthritis; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha | 2023 |
Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial.
Topics: Adalimumab; Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Prospective Studies; Spondylarthritis; Treatment Outcome; Young Adult | 2020 |
21 other study(ies) available for methotrexate and Arthritis, Spinal
| Article | Year |
|---|---|
Enthesitis-related arthritis and spondylarthritis: the same disease or disparate entities?
Topics: Adult; Arthritis, Juvenile; HLA-B27 Antigen; Humans; Methotrexate; Middle Aged; Quality of Life; Spondylarthritis | 2022 |
Combination of methotrexate and sulfasalazine is an efficacious option for axial spondyloarthritis in a resource-limited, real-world clinical setting: a prospective cohort study.
Topics: Antirheumatic Agents; Cohort Studies; Humans; Methotrexate; Prospective Studies; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome | 2021 |
Descriptive Comparisons of the Effect of Apremilast and Methotrexate Monotherapy in Oligoarticular Psoriatic Arthritis: The Corrona Psoriatic Arthritis/Spondyloarthritis Registry Results.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Drug Therapy, Combination; Humans; Methotrexate; Registries; Spondylarthritis; Thalidomide; Treatment Outcome | 2021 |
TNFi-induced sustained clinical remission in peripheral spondyloarthritis patients cannot be maintained with a step-down strategy based on methotrexate.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Prospective Studies; Recurrence; Remission Induction; Spondylarthritis; Time Factors; Tumor Necrosis Factor Inhibitors | 2021 |
Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis.
Topics: Adult; Arthritis, Rheumatoid; Chemokines; Cluster Analysis; Cytokines; Humans; Inflammation; Lymphocytes; Methotrexate; Middle Aged; Spondylarthritis | 2021 |
Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cross-Sectional Studies; Humans; Methotrexate; Spondylarthritis; Spondylitis, Ankylosing; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha | 2022 |
[Management of spondyloarthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Biological Products; Humans; Methotrexate; Spondylarthritis | 2018 |
Henoch-Schonlein purpura associated with HLA-B27 positive axial spondyloarthritis in a young man.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; HLA-B27 Antigen; Humans; IgA Vasculitis; Male; Methotrexate; Sacroiliitis; Spondylarthritis; Sulfasalazine; Tomography, X-Ray Computed | 2019 |
Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Bone Density; Drug Therapy, Combination; Etanercept; Female; Follow-Up Studies; Hip Joint; Humans; Immunoglobulin G; Infliximab; Lumbar Vertebrae; Male; Methotrexate; Middle Aged; Radiography; Receptors, Tumor Necrosis Factor; Spondylarthritis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Prospective Studies; Receptors, Tumor Necrosis Factor; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Anti-TNFα agents and methotrexate in spondyloarthritis related uveitis in a Chinese population.
Topics: Adalimumab; Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Blindness; Child; Child, Preschool; China; Drug Therapy, Combination; Etanercept; Female; Humans; Infliximab; Male; Methotrexate; Retrospective Studies; Spondylarthritis; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Young Adult | 2015 |
Brief Report: Management of Chronic Post-Chikungunya Rheumatic Disease: The Martinican Experience.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis; Bursitis; Carpal Tunnel Syndrome; Chikungunya Fever; Chronic Disease; Epidemics; Female; Fibromyalgia; Humans; Low Back Pain; Male; Martinique; Methotrexate; Middle Aged; Osteoarthritis; Rheumatic Diseases; Spondylarthritis; Tendinopathy; Tumor Necrosis Factor-alpha | 2016 |
Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway.
Topics: Adult; Age Distribution; Antirheumatic Agents; Arthritis, Psoriatic; Cohort Studies; Confidence Intervals; Disease Progression; Female; HLA-B27 Antigen; Humans; Incidence; Male; Methotrexate; Norway; Odds Ratio; Poisson Distribution; Probability; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Distribution; Spondylarthritis; Statistics, Nonparametric | 2009 |
Efficacy of SLZ and MTX (alone or combination) on the treatment of active sacroiliitis in early AS.
Topics: Adult; Antirheumatic Agents; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Retrospective Studies; Sacroiliac Joint; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine; Treatment Outcome | 2009 |
Unusual cervical spine involvement in psoriatic arthritis: a case series.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Cervical Vertebrae; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Male; Meloxicam; Methotrexate; Middle Aged; Neck Pain; Orthopedic Fixation Devices; Range of Motion, Articular; Spondylarthritis; Spondylitis, Ankylosing; Thiazines; Thiazoles; Tramadol | 2009 |
Registry of the clinical characteristics of spondyloarthritis in a cohort of Egyptian population.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Cross-Sectional Studies; Disability Evaluation; Egypt; Female; HLA-B27 Antigen; Humans; Male; Methotrexate; Middle Aged; Quality of Life; Registries; Severity of Illness Index; Socioeconomic Factors; Spondylarthritis; Steroids; Sulfasalazine; Treatment Outcome | 2012 |
Biological drug treatment of rheumatoid arthritis and spondyloarthritis: effects on QT interval and QT dispersion.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Electrocardiography; Etanercept; Humans; Immunoglobulin G; Infliximab; Methotrexate; Myocardial Contraction; Receptors, Tumor Necrosis Factor; Retrospective Studies; Rituximab; Spondylarthritis; Tumor Necrosis Factor-alpha | 2012 |
Cutaneous polyarteritis nodosa associated with HLA-B39-positive undifferentiated spondyloarthritis in a Japanese patient.
Topics: Adult; Biomarkers; Glucocorticoids; HLA-B39 Antigen; Humans; Immunosuppressive Agents; Male; Methotrexate; Polyarteritis Nodosa; Prednisolone; Skin; Skin Diseases; Spondylarthritis; Treatment Outcome | 2012 |
Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Follow-Up Studies; Humans; Male; Methotrexate; Randomized Controlled Trials as Topic; Reproducibility of Results; Risk Assessment; Severity of Illness Index; Spondylarthritis; Treatment Outcome | 2012 |
Unmasking of axial spondyloarthritis and oligoarthritis following discontinuation of tumour necrosis factor inhibitor therapy for psoriasis.
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Cyclosporine; Drug Substitution; Humans; Immunosuppressive Agents; Knee Injuries; Male; Methotrexate; Osteoarthritis, Knee; Psoriasis; Spondylarthritis; Tumor Necrosis Factor-alpha; Ustekinumab; Withholding Treatment | 2014 |
[Spondylarthritides].
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Child; Diagnostic Imaging; Etanercept; Female; HLA-B27 Antigen; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Physical Therapy Modalities; Receptors, Tumor Necrosis Factor; Spine; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine | 2006 |